Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caitlin N Kent

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
ACS Chemical Neuroscience|May 22, 2020
Classics in Chemical Neuroscience: BaclofenCaitlin N Kent, Charlotte Park, Craig W Lindsley
Chemmedchem|October 24, 2017
Synthesis and Biological Evaluation of Stilbene Analogues as Hsp90 C-Terminal InhibitorsKatherine M Byrd, Caitlin N Kent, Brian S J Blagg
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 27, 2021
Structure-Based Design, Synthesis, and Biological Evaluation of Hsp90β-Selective InhibitorsSubhabrata Chaudhury, Penchala Narasimharao Meka, Monimoy Banerjee, et al.
Journal of Medicinal Chemistry|March 13, 2018
Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective BindingNanette L S Que, Vincent M Crowley, Adam S Duerfeldt, et al.
Journal of Medicinal Chemistry|January 11, 2021
The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with <i>pan</i>-Hsp90 InhibitionSanket J Mishra, Weiya Liu, Kristin Beebe, et al.
Nature Communications|February 1, 2018
Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitorAnuj Khandelwal, Caitlin N Kent, Maurie Balch, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2021
Discovery and optimization of a novel CNS penetrant series of mGlu<sub>4</sub> PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian modelCaitlin N Kent, Mark G Fulton, Kaylee J Stillwell, et al.
Molecular Pharmacology|March 5, 2022
VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium ChannelsSamantha J McClenahan, Caitlin N Kent, Sujay V Kharade, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
ACS Chemical Neuroscience|May 22, 2020
Classics in Chemical Neuroscience: BaclofenCaitlin N Kent, Charlotte Park, Craig W Lindsley
Chemmedchem|October 24, 2017
Synthesis and Biological Evaluation of Stilbene Analogues as Hsp90 C-Terminal InhibitorsKatherine M Byrd, Caitlin N Kent, Brian S J Blagg
Chemistry (Weinheim an Der Bergstrasse, Germany)|August 27, 2021
Structure-Based Design, Synthesis, and Biological Evaluation of Hsp90β-Selective InhibitorsSubhabrata Chaudhury, Penchala Narasimharao Meka, Monimoy Banerjee, et al.
Journal of Medicinal Chemistry|March 13, 2018
Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective BindingNanette L S Que, Vincent M Crowley, Adam S Duerfeldt, et al.
Journal of Medicinal Chemistry|January 11, 2021
The Development of Hsp90β-Selective Inhibitors to Overcome Detriments Associated with <i>pan</i>-Hsp90 InhibitionSanket J Mishra, Weiya Liu, Kristin Beebe, et al.
Nature Communications|February 1, 2018
Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitorAnuj Khandelwal, Caitlin N Kent, Maurie Balch, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2021
Discovery and optimization of a novel CNS penetrant series of mGlu<sub>4</sub> PAMs based on a 1,4-thiazepane core with in vivo efficacy in a preclinical Parkinsonian modelCaitlin N Kent, Mark G Fulton, Kaylee J Stillwell, et al.
Molecular Pharmacology|March 5, 2022
VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium ChannelsSamantha J McClenahan, Caitlin N Kent, Sujay V Kharade, et al.
Pageof 1